VERSARIEN PLC

Capital/Financing Update • Feb 26, 2021

National Storage Mechanism | Additional information

RNS Number : 5015Q

Versarien PLC

26 February 2021

26 February 2021

Versarien plc

("Versarien" or the "Company")

Innovate UK Loan

Versarien plc (AIM: VRS), the advanced materials engineering group provides the following update regarding the Innovate UK ("IUK") loan facility, details of which were previously notified on 1 July 2020 and 17 August 2020.  The interim results announced on 21 January 2021 disclosed the loan balance of £1.96 million in "Non-current liabilities" under "Trade and other payables".

In light of the paper published by the International Financial Reporting Interpretations Committee in December 2020, subsequent to the Company's half-year end, the Company announces that the IUK loan balance at 31 March 2021 will, in the Company's annual results, continue to be classified under the "Non-current liabilities" heading on the balance sheet but will be shown as a separate line item. This treatment has been agreed with its auditor, PwC.

Enquiries:

Versarien Neill Ricketts, CEO Chris Leigh, CFO	+44 (0)1242 269 122
SP Angel Corporate Finance (Nominated Adviser and Joint Broker) Matthew Johnson, Ewan Leggat, Adam Cowl	+44 (0)20 3470 0470
Berenberg (Joint Broker) Mark Whitmore, Simon Cardron	+44 (0)20 3207 7800
Yellow Jersey (Investor Relations)  Charles Goodwin Georgia Colkin Henry Wilkinson Versarien@yellowjerseypr.com	+44 (0)774 778 8221

Notes to Editors:

Versarien Plc (AIM:VRS), is an advanced engineering materials group. Leveraging proprietary technology, the Group creates innovative engineering solutions for its clients in a diverse range of industries.

For further information please see: http://www.versarien.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCEAEAKAFAFEFA